DrugPatentWatch Database Preview
Patent: 8,206,748
Summary for Patent: 8,206,748
| Title: | Powdery composition for nasal administration |
| Abstract: | A powdery composition for nasal administration, where (1) the composition contains (i) a drug, (ii) a water-absorbing and gel-forming base material such as hydroxypropyl cellulose or hydroxypropylmethyl cellulose and (iii) a water-absorbing and water-insoluble base material such as crystalline cellulose or .alpha.-cellulose, (2) wherein the amount of the water-absorbing and gel-forming base material is about 5-40 wt % based on the total of the water-absorbing and gel-forming base material and the water-absorbing and water-insoluble base material, and (3) wherein the drug is unevenly dispersed more on/in the water-absorbing and water-insoluble base material than on/in the water-absorbing and gel-forming base material. |
| Inventor(s): | Dohi; Masahiko (Tokyo, JP), Nishibe; Yoshihisa (Tokyo, JP), Makino; Yuji (Tokyo, JP), Fujii; Takao (Tokyo, JP) |
| Assignee: | Teijin Limited (Osaka, JP) |
| Application Number: | 12/610,901 |
| Patent Claims: | see list of patent claims |
Details for Patent 8,206,748
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 004 | 2015-01-23 | Start Trial | Teijin Limited (Osaka, JP) | 2016-02-27 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 003 | 2015-01-23 | Start Trial | Teijin Limited (Osaka, JP) | 2016-02-27 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 002 | 2015-01-23 | Start Trial | Teijin Limited (Osaka, JP) | 2016-02-27 | RX | Orphan | search |
| Nps Pharms Inc | NATPARA | parathyroid hormone | INJECTABLE;INJECTION | 125511 | 001 | 2015-01-23 | Start Trial | Teijin Limited (Osaka, JP) | 2016-02-27 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,206,748
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 9731626 | Sep 04, 1997 |
| United States of America | 2002012688 | Jan 31, 2002 |
| United States of America | 2004219108 | Nov 04, 2004 |
| United States of America | 2010047206 | Feb 25, 2010 |
| >Country | >Patent Number | >Publication Date |
